ASX investors support wound care start-up
Biotechnology start-up Next Science (ASX: NXS) has shown Australian investors are prepared to support a research based manufacturer with an impressive debut on the stock exchange. Shares in Sydney-based Next Science, which carries our research and operations in the United States, rose 35 per cent on listing last week to $1.35. More than $35 million…